Allergy Asthma Respir Dis.  2013 Jun;1(2):105-110. 10.4168/aard.2013.1.2.105.

Adherence: implications for asthma treatment

Affiliations
  • 1Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea. dr202202@naver.com

Abstract

Adherence is defined as 'the extent to which a patient's behavior corresponds with recommendations from a health care provider'. In all chronic diseases, including asthma, patient nonadherence to medical recommendations is common. In asthma, low rates of adherence to preventive medication are associated with higher rates of hospitalization and death. Many patients choose not to take their medication because they perceive it to be unnecessary or because they are concerned about potential adverse effects. Approximately one third of asthma patients have strong concerns about adverse effects from inhaled corticosteroids (ICSs). Clinicians must be prepared to work in an ongoing partnership with patients to ensure that they are offered a clear rationale as to why ICS are necessary and to address their concerns about potential adverse effects. This approach, based on a detailed examination of patients' perspectives on asthma and its treatment, and an open, nonjudgmental manner on the part of the clinician, is consistent with the idea of concordance. Both the efficacy of a medication and patient adherence to the therapeutic regimen influence the effectiveness of a treatment. This article will review the underlying reasons for patient nonadherence and describe the role played by clinicians in promoting optimal medicine management.

Keyword

Guideline adherence; Asthma; Patient nonadherence

MeSH Terms

Adrenal Cortex Hormones
Asthma
Chronic Disease
Delivery of Health Care
Dietary Sucrose
Guideline Adherence
Hospitalization
Humans
Patient Compliance
Adrenal Cortex Hormones
Dietary Sucrose

Figure

  • Fig. 1 Barriers to adherence can be categorized as related to the characteristics of the disease, the therapy required, the individual patient, the clinician, the practice and health system, or general societal conditions. Adapted from World Health Organization.7)


Cited by  1 articles

The Association between Chronic Diseases and Active Patient Participation
Yang Keun Kim, Hye Won Kim, Jae Yong Paik, Chang Bin Hong, Kayoung Lee, Tae-Jin Park, Jinseung Kim
Korean J Health Promot. 2017;17(3):152-160.    doi: 10.15384/kjhp.2017.17.3.152.


Reference

1. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975; 13:10–24.
Article
2. Haynes RB, Taylor DW, Sackett DL. Compliance in healthcare. Baltimore: Johns Hopkins University Press;1979.
3. The Global Initiative for Asthma. GINA Report, Global Strategy for Asthma Management and Prevention. Updated Dec. 2011 [Internet]. cited 2012 Oct 31. The Global Initiative For Asthma;c2011. Available from: http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html.
4. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002; 17:17–32.
Article
5. Foster J, Aucott L, van der Werf R, van der Meijden MJ, van der Molen GS. Many patients perceive numerous side effects of inhaled corticosteroids. Primary Care Respir. 2003; 12:68–69.
Article
6. Becker MH. Patient adherence to prescribed therapies. Med Care. 1985; 23:539–555.
Article
7. Sabate E. Adherence to long-term therapies: evidence for action, non-communicable disease and health adherence to long term therapies project. Geneva, Switzerland: World Health Organization;2003.
8. Horne R. Concordance and medicines management in the respiratory arena. London, UK: Hayward Medical Publications;2003.
9. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol. 1997; 79:177–185.
10. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol. 1996; 98(6 Pt 1):1051–1057.
Article
11. Kim C, Feldman HI, Joffe M, Tenhave T, Boston R, Apter AJ. Influences of earlier adherence and symptoms on current symptoms: a marginal structural models analysis. J Allergy Clin Immunol. 2005; 115:810–814.
Article
12. Krishnan JA, Riekert KA, McCoy JV, Stewart DY, Schmidt S, Chanmugam A, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med. 2004; 170:1281–1285.
Article
13. Onyirimba F, Apter A, Reisine S, Litt M, McCusker C, Connors M, et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy Asthma Immunol. 2003; 90:411–415.
Article
14. Bender BG. Screening patients for nonadherence. Female Patient. 2005; 30:1–4.
15. Diette GB, Wu AW, Skinner EA, Markson L, Clark RD, McDonald RC, et al. Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids. Arch Intern Med. 1999; 159:2697–2704.
Article
16. Mawhinney H, Spector SL, Kinsman RA, Siegel SC, Rachelefsky GS, Katz RM, et al. Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy. 1991; 66:294–299.
17. Rand CS, Wise RA, Nides M, Simmons MS, Bleecker ER, Kusek JW, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992; 146:1559–1564.
Article
18. Cochrane GM, Horne R, Chanez P. Compliance in asthma. Respir Med. 1999; 93:763–769.
Article
19. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24:67–74.
Article
20. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004; 42:200–209.
21. Weinman J. Providing written information for patients: psychological considerations. J R Soc Med. 1990; 83:303–305.
Article
22. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004; 42:102–109.
Article
23. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47:555–567.
Article
24. Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS. 2004; 15:38–44.
Article
25. Aikens JE, Nease DE Jr, Nau DP, Klinkman MS, Schwenk TL. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med. 2005; 3:23–30.
Article
26. Main J, Weinman J, Horne R. Explaining adherence to preventer medication in asthma. Int J Behav Med. 2004; 11:Suppl. 72.
27. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005; (4):CD000011.
28. Bailey WC, Richards JM Jr, Brooks CM, Soong SJ, Windsor RA, Manzella BA. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990; 150:1664–1668.
Article
29. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy. 2001; 21:1464–1467.
Article
30. Iskedjian M, Einarson TR, MacKeigan LD, Shear N, Addis A, Mittmann N, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002; 24:302–316.
Article
31. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol. 2004; 113:245–251.
Article
32. Venables TL, Addlestone MB, Smithers AJ. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbuhaler and twice daily fluticasone propionate via a disc-inhaler at an equal dose of 400 mcg in adult asthmatics. Br J Clin Res. 1996; 7:15–32.
33. DiMatteo MR, Sherbourne CD, Hays RD, Ordway L, Kravitz RL, McGlynn EA, et al. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol. 1993; 12:93–102.
Article
34. Roter DL, Hall JA. Strategies for enhancing patient adherence to medical recommendations. JAMA. 1994; 271:80.
Article
35. Wissow LS, Roter D, Bauman LJ, Crain E, Kercsmar C, Weiss K, et al. Patient-provider communication during the emergency department care of children with asthma. The National Cooperative Inner-City Asthma Study, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD. Med Care. 1998; 36:1439–1450.
Article
36. Clark NM, Gong M, Schork MA, Kaciroti N, Evans D, Roloff D, et al. Long-term effects of asthma education for physicians on patient satisfaction and use of health services. Eur Respir J. 2000; 16:15–21.
Article
Full Text Links
  • AARD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr